Transmembrane voltage potential is an essential cellular parameter for the detection and control of tumor development in a Xenopus model

DMM Disease Models and Mechanisms

Volumn 6, Issue 3, 2013, Pages 595-607

  Chernet, Brook T ^a   Levin, Michael ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; PROTEIN P53; SLC5A8 PROTEIN; TRANSCRIPTION FACTOR GLI1; TUMOR MARKER; UNCLASSIFIED DRUG; XREL3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CONTROL; CARCINOGENESIS; ELECTRIC POTENTIAL; EMBRYO; GENE OVEREXPRESSION; HYPERPOLARIZATION; IN VIVO STUDY; MEMBRANE POTENTIAL; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; TUMOR DIAGNOSIS; XENOPUS LAEVIS;

ANIMALS; BUTYRATES; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; EMBRYO, NONMAMMALIAN; GENETIC TESTING; HUMANS; MEMBRANE POTENTIALS; MODELS, BIOLOGICAL; MUTANT PROTEINS; ONCOGENES; SUPPRESSION, GENETIC; TUMOR SUPPRESSOR PROTEINS; XENOPUS LAEVIS; XENOPUS PROTEINS;

EID: 84877820172     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.010835     Document Type: Article

References (109)

1. Abdul, M. and Hoosein, N. (2002a). Voltage-gated potassium ion channels in colon cancer. Oncol. Rep. 9, 961-964.
2. Abdul, M. and Hoosein, N. (2002b). Voltage-gated sodium ion channels in prostate cancer: expression and activity. Anticancer Res. 22, 1727-1730.
3. Aberg, P., Nicander, I., Hansson, J., Geladi, P., Holmgren, U. and Ollmar, S. (2004). Skin cancer identification using multifrequency electrical impedance - a potential screening tool. IEEE Trans. Biomed. Eng. 51, 2097-2102.
4. Adams, D. S. (2008). A new tool for tissue engineers: ions as regulators of morphogenesis during development and regeneration. Tissue Eng. Part A 14, 1461-1468.
5. Adams, D. S. and Levin, M. (2012a). Endogenous voltage gradients as mediators of cell-cell communication: strategies for investigating bioelectrical signals during pattern formation. Cell Tissue Res. doi:10.1007/s00441-012-1329- 4 [Epub ahead of print].
6. Adams, D. S. and Levin, M. (2012b). General principles for measuring resting membrane potential and ion concentration using fluorescent bioelectricity reporters. Cold Spring Harb. Protoc. 2012, 385-397.
7. Adams, D. S. and Levin, M. (2012c). Measuring resting membrane potential using the fluorescent voltage reporters DiBAC4(3) and CC2-DMPE. Cold Spring Harb. Protoc. 2012, 459-464.
8. +-V-ATPase-dependent proton flux is necessary for consistent left-right patterning of non-mammalian vertebrates. Development 133, 1657-1671.
9. + pump-dependent changes in membrane voltage are an early mechanism necessary and sufficient to induce Xenopus tail regeneration. Development 134, 1323-1335.
10. + current with a cellcycle dependence governs the resting potential of mammalian neuroblastoma cells. J. Physiol. 489, 455-471.
11. Arcangeli, A., Crociani, O., Lastraioli, E., Masi, A., Pillozzi, S. and Becchetti, A. (2009). Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr. Med. Chem. 16, 66-93.
12. Arcangeli, A., Pillozzi, S. and Becchetti, A. (2012). Targeting ion channels in leukemias: a new challenge for treatment. Curr. Med. Chem. 19, 683-696.
13. Aw, S., Adams, D. S., Qiu, D. and Levin, M. (2008). H,K-ATPase protein localization and Kir4.1 function reveal concordance of three axes during early determination of left-right asymmetry. Mech. Dev. 125, 353-372.
14. Bandyopadhyay, D., Mishra, A. and Medrano, E. E. (2004). Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway. Cancer Res. 64, 7706-7710.
15. Bast, R. C., Jr, Ravdin, P., Hayes, D. F., Bates, S., Fritsche, H., Jr, Jessup, J. M., Kemeny, N., Locker, G. Y., Mennel, R. G. and Somerfield, M. R. (2001). 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 19, 1865-1878.
16. Beane, W. S., Morokuma, J., Adams, D. S. and Levin, M. (2011). A chemical genetics approach reveals H,K-ATPase-mediated membrane voltage is required for planarian head regeneration. Chem. Biol. 18, 77-89.
17. Becchetti, A. (2011). Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer. Am. J. Physiol. Cell Physiol. 301, C255-C265.
18. Binggeli, R. and Weinstein, R. C. (1986). Membrane potentials and sodium channels: hypotheses for growth regulation and cancer formation based on changes in sodium channels and gap junctions. J. Theor. Biol. 123, 377-401.
19. Blackiston, D. J., McLaughlin, K. A. and Levin, M. (2009). Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle. Cell Cycle 8, 3527-3536.
20. Blackiston, D., Adams, D. S., Lemire, J. M., Lobikin, M. and Levin, M. (2011). Transmembrane potential of GlyCl-expressing instructor cells induces a neoplastic-like conversion of melanocytes via a serotonergic pathway. Dis. Model. Mech. 4, 67-85.
21. + channels: potential for beta subunits as therapeutic targets. Expert Opin. Ther. Targets 12, 1191-1203.
22. + channels in cellular migration: regulation of central nervous system development and potentiation of invasive cancers. Neuroscientist 14, 571-583.
23. Brooks, R. A. and Woodruff, R. I. (2004). Calmodulin transmitted through gap junctions stimulates endocytic incorporation of yolk precursors in insect oocytes. Dev. Biol. 271, 339-349.
24. Bukreeva, E. I., Aksenov, N. D., Bardin, A. A., Pospelov, V. A. and Pospelova, T. V. (2009). [Effect of histone deacetylases inhibitor sodium butyrate (NaB) on transformants E1A + cHa-Ras expressing wild type p53 with supressed transactivation function]. Tsitologiia 51, 697-705.
25. Burr, H. S. (1940). Biologic organization and the cancer problem. Yale J. Biol. Med. 12, 277-282.
26. Burr, H. S. (1941). Changes in the field properties of mice with transplanted tumors. Yale J. Biol. Med. 13, 783-788.
27. Burr, H. S., Strong, L. C. and Smith, G. M. (1938). Bio-electric correlates of methylcolanthrene-induced Tumors in mice. Yale J. Biol. Med. 10, 539-544.
28. Burr, H. S., Smith, G. M. and Strong, L. C. (1940). Electrometric studies of tumors in mice induced by the external application of benzpyrene. Yale J. Biol. Med. 12, 711-717.
29. Cameron, I. L. and Smith, N. K. (1989). Cellular concentration of magnesium and other ions in relation to protein synthesis, cell proliferation and cancer. Magnesium 8, 31-44.
30. Cameron, I. L., Smith, N. K., Pool, T. B. and Sparks, R. L. (1980). Intracellular concentration of sodium and other elements as related to mitogenesis and oncogenesis in vivo. Cancer Res. 40, 1493-1500.
31. Chatterjee, S. K. and Zetter, B. R. (2005). Cancer biomarkers: knowing the present and predicting the future. Future Oncol. 1, 37-50.
32. Clement, V., Sanchez, P., de Tribolet, N., Radovanovic, I. and Ruiz i Altaba, A. (2007). HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 17, 165-172.
33. +-monocarboxylate cotransporter. J. Physiol. 557, 719-731.
34. Cone, C. D., Jr (1971). Unified theory on the basic mechanism of normal mitotic control and oncogenesis. J. Theor. Biol. 30, 151-181.
35. Cone, C. D., Jr and Tongier, M., Jr (1971). Control of somatic cell mitosis by simulated changes in the transmembrane potential level. Oncology 25, 168-182.
36. Costa, R. M., Mason, J., Lee, M., Amaya, E. and Zorn, A. M. (2003). Novel gene expression domains reveal early patterning of the Xenopus endoderm. Gene Expr. Patterns 3, 509-519.
37. Dahmane, N., Lee, J., Robins, P., Heller, P. and Ruiz i Altaba, A. (1997). Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 389, 876-881.
38. Davie, J. R. (2003). Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133 Suppl., 2485S-2493S.
39. + channels: multiplicity of expression, plasticity, functional implications and pathophysiological aspects. Eur. Biophys. J. 33, 180-193.
40. Etchin, J., Kanki, J. P. and Look, A. T. (2011). Zebrafish as a model for the study of human cancer. Methods Cell Biol. 105, 309-337.
41. Farias, L. M., Ocaña, D. B., Díaz, L., Larrea, F., Avila-Chávez, E., Cadena, A., Hinojosa, L. M., Lara, G., Villanueva, L. A., Vargas, C. et al. (2004). Ether a go-go potassium channels as human cervical cancer markers. Cancer Res. 64, 6996-7001.
42. Fiske, J. L., Fomin, V. P., Brown, M. L., Duncan, R. L. and Sikes, R. A. (2006). Voltage-sensitive ion channels and cancer. Cancer Metastasis Rev. 25, 493-500.
43. Fukumoto, T., Blakely, R. and Levin, M. (2005a). Serotonin transporter function is an early step in left-right patterning in chick and frog embryos. Dev. Neurosci. 27, 349-363.
44. Fukumoto, T., Kema, I. P. and Levin, M. (2005b). Serotonin signaling is a very early step in patterning of the left-right axis in chick and frog embryos. Curr. Biol. 15, 794-803.
45. Gilmore, T. D., Kalaitzidis, D., Liang, M. C. and Starczynowski, D. T. (2004). The c-Rel transcription factor and B-cell proliferation: a deal with the devil. Oncogene 23, 2275-2286.
46. Gopal, E., Fei, Y. J., Sugawara, M., Miyauchi, S., Zhuang, L., Martin, P., Smith, S. B., Prasad, P. D. and Ganapathy, V. (2004). Expression of slc5a8 in kidney and its role in Na(+)-coupled transport of lactate. J. Biol. Chem. 279, 44522-44532.
47. Gupta, N., Martin, P. M., Prasad, P. D. and Ganapathy, V. (2006). SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sci. 78, 2419-2425.
48. Heneghan, H. M., Miller, N., Lowery, A. J., Sweeney, K. J., Newell, J. and Kerin, M. J. (2010). Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann. Surg. 251, 499-505.
49. + channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res. 70, 6957-6967.
50. Huang, S., Ernberg, I. and Kauffman, S. (2009). Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective. Semin. Cell Dev. Biol. 20, 869-876.
51. Jiang, X. M., Kong, J., Lin, T., Yu, X. Y., Chen, Y., Dai, Y., Yang, H. Y., Sun, X. L., Yang, J., Yang, Y. Q. et al. (2003). [Study on the clinical use of alpha-fetoprotein (AFP) colloidal gold diagnostic strip]. Zhonghua Liu Xing Bing Xue Za Zhi 24, 210-212.
52. Jing, L. and Zon, L. I. (2011). Zebrafish as a model for normal and malignant hematopoiesis. Dis. Model. Mech. 4, 433-438.
53. Kunzelmann, K. (2005). Ion channels and cancer. J. Membr. Biol. 205, 159-173.
54. Lagger, G., Doetzlhofer, A., Schuettengruber, B., Haidweger, E., Simboeck, E., Tischler, J., Chiocca, S., Suske, G., Rotheneder, H., Wintersberger, E. et al. (2003). The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol. Cell. Biol. 23, 2669-2679.
55. Le, X., Langenau, D. M., Keefe, M. D., Kutok, J. L., Neuberg, D. S. and Zon, L. I. (2007). Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish. Proc. Natl. Acad. Sci. USA 104, 9410-9415.
56. Levin, M. (2007). Large-scale biophysics: ion flows and regeneration. Trends Cell Biol. 17, 261-270.
57. Levin, M. (2009). Bioelectric mechanisms in regeneration: unique aspects and future perspectives. Semin. Cell Dev. Biol. 20, 543-556.
58. Levin, M. (2012a). Molecular bioelectricity in developmental biology: new tools and recent discoveries: control of cell behavior and pattern formation by transmembrane potential gradients. Bioessays 34, 205-217.
59. Levin, M. (2012b). Morphogenetic fields in embryogenesis, regeneration, and cancer: non-local control of complex patterning. Biosystems 109, 243-261.
60. Levin, M. and Mercola, M. (1998). Gap junctions are involved in the early generation of left-right asymmetry. Dev. Biol. 203, 90-105.
61. +-ATPase and cell membrane potentials comprise a very early step in left-right patterning. Cell 111, 77-89.
62. Li, H., Myeroff, L., Smiraglia, D., Romero, M. F., Pretlow, T. P., Kasturi, L., Lutterbaugh, J., Rerko, R. M., Casey, G., Issa, J. P. et al. (2003). SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc. Natl. Acad. Sci. USA 100, 8412-8417.
63. Liu, S. and Leach, S. D. (2011). Zebrafish models for cancer. Annu. Rev. Pathol. 6, 71-93.
64. Marcus, D. C., Wu, T., Wangemann, P. and Kofuji, P. (2002). KCNJ10 (Kir4.1) potassium channel knockout abolishes endocochlear potential. Am. J. Physiol. Cell Physiol. 282, C403-C407.
65. McCaig, C. D., Rajnicek, A. M., Song, B. and Zhao, M. (2005). Controlling cell behavior electrically: current views and future potential. Physiol. Rev. 85, 943-978.
66. McCaig, C. D., Song, B. and Rajnicek, A. M. (2009). Electrical dimensions in cell science. J. Cell Sci. 122, 4267-4276.
67. McCue, P. A., Gubler, M. L., Sherman, M. I. and Cohen, B. N. (1984). Sodium butyrate induces histone hyperacetylation and differentiation of murine embryonal carcinoma cells. J. Cell Biol. 98, 602-608.
68. McNulty, S. E., del Rosario, R., Cen, D., Meyskens, F. L., Jr and Yang, S. (2004). Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies. Pigment Cell Res. 17, 173-180.
69. Mitas, M., Mikhitarian, K., Walters, C., Baron, P. L., Elliott, B. M., Brothers, T. E., Robison, J. G., Metcalf, J. S., Palesch, Y. Y., Zhang, Z. et al. (2001). Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int. J. Cancer 93, 162-171.
70. Miyauchi, S., Gopal, E., Fei, Y. J. and Ganapathy, V. (2004). Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids. J. Biol. Chem. 279, 13293-13296.
71. Morokuma, J., Blackiston, D., Adams, D. S., Seebohm, G., Trimmer, B. and Levin, M. (2008). Modulation of potassium channel function confers a hyperproliferative invasive phenotype on embryonic stem cells. Proc. Natl. Acad. Sci. USA 105, 16608-16613.
72. + of various normal, transformed, and tumor cells. J. Cell. Physiol. 113, 129-133.
73. 2+ entry: a way to control cell proliferation. Curr. Med. Chem. 11, 1533-1543.
74. Munaron, L., Antoniotti, S. and Lovisolo, D. (2004b). Intracellular calcium signals and control of cell proliferation: how many mechanisms? J. Cell. Mol. Med. 8, 161-168.
75. Nieuwkoop, P. D. and Faber, J. (1967). Normal Table of Xenopus laevis (Daudin). Amsterdam, Netherlands: North-Holland Publishing Company.
76. Nuccitelli, R. (2003). A role for endogenous electric fields in wound healing. Curr. Top. Dev. Biol. 58, 1-26.
77. Onkal, R. and Djamgoz, M. B. (2009). Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: clinical potential of neonatal Nav1.5 in breast cancer. Eur. J. Pharmacol. 625, 206-219.
78. Ouwerkerk, R., Jacobs, M. A., Macura, K. J., Wolff, A. C., Stearns, V., Mezban, S. D., Khouri, N. F., Bluemke, D. A. and Bottomley, P. A. (2007). Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI. Breast Cancer Res. Treat. 106, 151-160.
79. Oviedo, N. J., Nicolas, C. L., Adams, D. S. and Levin, M. (2008). Live imaging of planarian membrane potential using DiBAC4(3). CSH Protoc. 2008, 5055.
80. Pai, V. P., Aw, S., Shomrat, T., Lemire, J. M. and Levin, M. (2012). Transmembrane voltage potential controls embryonic eye patterning in Xenopus laevis. Development 139, 313-323.
81. Pardo, L. A., del Camino, D., Sánchez, A., Alves, F., Brüggemann, A., Beckh, S. and Stühmer, W. (1999). Oncogenic potential of EAG K(+) channels. EMBO J. 18, 5540-5547.
82. Pardo, L. A., Contreras-Jurado, C., Zientkowska, M., Alves, F. and Stühmer, W. (2005). Role of voltage-gated potassium channels in cancer. J. Membr. Biol. 205, 115-124.
83. + channel function. Proc. Natl. Acad. Sci. USA 100, 7803-7807.
84. Pereira, C., Coutinho, I., Soares, J., Bessa, C., Leão, M. and Saraiva, L. (2012). New insights into cancer-related proteins provided by the yeast model. FEBS J. 279, 697-712.
85. Prevarskaya, N., Skryma, R. and Shuba, Y. (2010). Ion channels and the hallmarks of cancer. Trends Mol. Med. 16, 107-121.
86. Ring, H., Mendu, S. K., Shirazi-Fard, S., Birnir, B. and Hallböök, F. (2012). GABA maintains the proliferation of progenitors in the developing chick ciliary marginal zone and non-pigmented ciliary epithelium. PLoS ONE 7, e36874.
87. Roepke, T. K., Purtell, K., King, E. C., La Perle, K. M., Lerner, D. J. and Abbott, G. W. (2010). Targeted deletion of Kcne2 causes gastritis cystica profunda and gastric neoplasia. PLoS ONE 5, e11451.
88. Roger, S., Rollin, J., Barascu, A., Besson, P., Raynal, P. I., Iochmann, S., Lei, M., Bougnoux, P., Gruel, Y. and Le Guennec, J. Y. (2007). Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines. Int. J. Biochem. Cell Biol. 39, 774-786.
89. Ross, J. S., Fletcher, J. A., Linette, G. P., Stec, J., Clark, E., Ayers, M., Symmans, W. F., Pusztai, L. and Bloom, K. J. (2003). The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist 8, 307-325.
90. Rubin, H. (1985). Cancer as a dynamic developmental disorder. Cancer Res. 45, 2935-2942.
91. +-ATPase (ductin) is accompanied by down-regulation of gap junctional intercellular communication and translocation of connexin 43 in NIH3T3 cells. Oncogene 17, 1673-1680.
92. Samowitz, W. S., Sweeney, C., Herrick, J., Albertsen, H., Levin, T. R., Murtaugh, M. A., Wolff, R. K. and Slattery, M. L. (2005). Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 65, 6063-6069.
93. Schönherr, R. (2005). Clinical relevance of ion channels for diagnosis and therapy of cancer. J. Membr. Biol. 205, 175-184.
94. Sive, H. L., Grainger, R. M. and Harland, R. M. (2000) Early Development of Xenopus laevis: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
95. Song, J. H., Francis, I. R., Platt, J. F., Cohan, R. H., Mohsin, J., Kielb, S. J., Korobkin, M. and Montie, J. E. (2001). Bladder tumor detection at virtual cystoscopy. Radiology 218, 95-100.
96. Stratton, M. R., Fisher, C., Gusterson, B. A. and Cooper, C. S. (1989). Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res. 49, 6324-6327.
97. Stühmer, W., Alves, F., Hartung, F., Zientkowska, M. and Pardo, L. A. (2006). Potassium channels as tumour markers. FEBS Lett. 580, 2850-2852.
98. Sundelacruz, S., Levin, M. and Kaplan, D. L. (2008). Membrane potential controls adipogenic and osteogenic differentiation of mesenchymal stem cells. PLoS ONE 3, e3737.
99. Sundelacruz, S., Levin, M. and Kaplan, D. L. (2009). Role of membrane potential in the regulation of cell proliferation and differentiation. Stem Cell Rev. 5, 231-246.
100. Thompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M., Lucia, M. S., Parnes, H. L., Minasian, L. M., Ford, L. G., Lippman, S. M., Crawford, E. D. et al. (2004). Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N. Engl. J. Med. 350, 2239-2246.
101. Tseng, A.-S. and Levin, M. (2012). Transducing bioelectric signals into epigenetic pathways during tadpole tail regeneration. Anat. Rec. 295, 1541-1551
102. Vafa, B., Lewis, T. M., Cunningham, A. M., Jacques, P., Lynch, J. W. and Schofield, P. R. (1999). Identification of a new ligand binding domain in the alpha1 subunit of the inhibitory glycine receptor. J. Neurochem. 73, 2158-2166.
103. Vandenberg, L. N., Morrie, R. D. and Adams, D. S. (2011). V-ATPase-dependent ectodermal voltage and pH regionalization are required for craniofacial morphogenesis. Dev. Dyn. 240, 1889-1904.
104. Waldner, C., Roose, M. and Ryffel, G. U. (2009). Red fluorescent Xenopus laevis: a new tool for grafting analysis. BMC Dev. Biol. 9, 37.
105. Wallingford, J. B., Seufert, D. W., Virta, V. C. and Vize, P. D. (1997). p53 activity is essential for normal development in Xenopus. Curr. Biol. 7, 747-757.
106. Wang, J., Xu, Y. Q., Liang, Y. Y., Gongora, R., Warnock, D. G. and Ma, H. P. (2007). An intermediate-conductance Ca(2+)-activated K(+) channel mediates B lymphoma cell cycle progression induced by serum. Pflugers Arch. 454, 945-956.
107. Yang, S., Lockwood, A., Hollett, P., Ford, R. and Kao, K. (1998). Overexpression of a novel Xenopus rel mRNA gene induces tumors in early embryos. J. Biol. Chem. 273, 13746-13752.
108. Yoshida, M., Kijima, M., Akita, M. and Beppu, T. (1990). Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265, 17174-17179.
109. Zernicka-Goetz, M., Pines, J., Ryan, K., Siemering, K. R., Haseloff, J., Evans, M. J. and Gurdon, J. B. (1996). An indelible lineage marker for Xenopus using a mutated green fluorescent protein. Development 122, 3719-3724.